Skuny BioScience Co., Ltd. – Trademark Portfolio
Entity Type: 99
Skuny BioScience Co., Ltd. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 29 (Meats & Processed Foods) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 3 are pending. Notable registered marks include MEGAFULLIFE and MEGAFULLPET. The owner is based in CHENGDU, SICHUAN.
NO. 81,UPPER SECTION OF INDUSTRIAL
AVENUE, HESHAN TOWN, PUJIANG
CHENGDU, SICHUAN 611630 , CN
Showing of trademarks Trademarks
Trademark Classifications
Skuny BioScience Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does Skuny BioScience Co., Ltd. have?
Skuny BioScience Co., Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 pending.
What trademark classes does Skuny BioScience Co., Ltd. file in?
Skuny BioScience Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Skuny BioScience Co., Ltd.'s most well-known trademarks?
Skuny BioScience Co., Ltd.'s registered trademark portfolio includes well-known marks such as MEGAFULLIFE and MEGAFULLPET. These are among 2 currently registered trademarks in the portfolio.
What is Skuny BioScience Co., Ltd.'s trademark registration success rate?
Skuny BioScience Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 3 applications are pending review.